Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis. - Wikidata - wikimedia - TriplyDB

Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.

Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.

http://www.wikidata.org/entity/Q33716459

about

Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice.Reciprocal interactions between bile acids and gut microbiota in human liver diseases.Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling.Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice.NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Autotaxin upregulated by STAT3 activation contributes to invasion in pancreatic neuroendocrine neoplasms Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis

P2860

Q41670848-EC13D00A-5F95-4349-8BBD-1738B4C5E997 Q46640064-F657F081-445F-4D52-BFF2-CF7E5F50A5AA Q47389652-B2A6FA75-9D88-4EEA-A291-253BF4786D7E Q49951562-83F0AB69-913D-46F8-A835-7DA6931D21C7 Q52699090-A0C528E9-EEBF-4BAB-BE21-87AB06A15053 Q57110523-997A3962-A012-4BEE-8FAB-A9C81D13BF4C Q57818887-7C70550A-68D9-4023-8C28-677F2476E272 Q58707687-B4DD35B2-2139-4683-94ED-E986637FDFA8

P2860

Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.

http://www.wikidata.org/entity/Q33716459

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Non-cell-autonomous activation ...... 9-driven hepatocarcinogenesis.

@ast

Non-cell-autonomous activation ...... 9-driven hepatocarcinogenesis.

@en

type

label

Non-cell-autonomous activation ...... 9-driven hepatocarcinogenesis.

@ast

Non-cell-autonomous activation ...... 9-driven hepatocarcinogenesis.

@en

prefLabel

Non-cell-autonomous activation ...... 9-driven hepatocarcinogenesis.

@ast

Non-cell-autonomous activation ...... 9-driven hepatocarcinogenesis.

@en

P1433

Q33716459-8213E7A6-558D-4E5E-9F0F-C595899AC152

P1476

Q33716459-608ADE29-BAE9-48F2-8218-43CCF130F271

P2093

Q33716459-19392CB0-A79C-40B9-A5C1-C2250886835D

Q33716459-25013065-36A1-427E-97D3-90AF57CC4AAC

Q33716459-8481EF32-D382-4567-916F-5521A53E4AC2

Q33716459-85D39A53-D450-41B5-930A-65C0BCD39465

Q33716459-87593BCC-618C-4342-9AE2-EDC2E2B25741

P2860

Q33716459-002D8E4B-744D-4A46-B683-AF1F455FCB5C

Q33716459-011DA8F8-8C4C-4BF1-9578-D488323DE54B

Q33716459-0D2D584E-D1A0-4171-932E-BA1227040BB9

Q33716459-1ED7C7CC-AB9E-421B-8B12-0479CB8AC6F1

Q33716459-2BCDE0BD-307F-4081-AD65-4A6C11DA256D

Q33716459-2F8CF2AB-7E05-4F3F-BE26-A7BAF9A6594A

Q33716459-39BEA22C-EED7-4D0F-995A-E9FC1445B020

Q33716459-4087C680-2B59-40F6-8738-0028A2F10506

Q33716459-43F37BA3-DDFD-46B1-A0D5-4458F8242C3F

Q33716459-445199CF-CC29-4050-917D-FDDBEC39BDEA

P2888

Q33716459-8AA89320-A896-41C1-AAB6-CA5C9911D717

P304

Q33716459-52B82877-C571-4D3B-9A9D-142193DF5C89

P31

Q33716459-A73FD0E4-F610-4571-B64B-38E2E045DE16

P356

Q33716459-8C73EC6C-6D3F-48E9-87C7-331796248D21

P407

Q33716459-3D001CF7-693D-4022-A210-1322317F9BD8

P478

Q33716459-3BD3EE55-9092-491E-A05E-C1DD891E6B3C

P577

Q33716459-137A1D26-0921-462F-9571-AEEF067D59D9

P6179

Q33716459-9592E874-83A7-41CA-BE32-FE93C8E04374

P698

Q33716459-D4E27D9D-6671-4F6A-9A3B-CAA4A8189652

P932

Q33716459-F788077C-2CC5-4522-B204-CA0DBB59CE9B

P356

P1433

Nature Communications

P1476

Non-cell-autonomous activation ...... 9-driven hepatocarcinogenesis.

@en

P2093

Hong Yang

http://www.w3.org/2001/XMLSchema#string

Hui Tian

http://www.w3.org/2001/XMLSchema#string

Lei Ling

http://www.w3.org/2001/XMLSchema#string

Mei Zhou

http://www.w3.org/2001/XMLSchema#string

R Marc Learned

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular signaling by fibroblast growth factor receptors

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis

A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

Significance of CD90+ cancer stem cells in human liver cancer

Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system

P2888

P304

15433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS15433

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085415102

http://www.w3.org/2001/XMLSchema#string

P698

28508871

http://www.w3.org/2001/XMLSchema#string

P932

5440856

http://www.w3.org/2001/XMLSchema#string